USPTO trademark

INVEA

AllowedUSPTOWord markClass 1Class 5

"INVEA" is a word mark owned by Invea Therapeutics, Inc., filed at the USPTO on April 3, 2023. It has been allowed and covers classes 1 and 5.

Get this data via the API

Data current as of October 12, 2026Official USPTO record

As filed with the USPTO

Status: Allowed; Since October 12, 2026
Filed: April 3, 2023
Registered: Not yet
Expires: Not recorded
Application no.: 97869600
Registration no.: Not yet
Office: USPTO; United States Patent and Trademark Office
Mark type: Word mark; 2 classes

Ownership

Who owns INVEA

The owner and representative on file with the office.

Owner

Invea Therapeutics, Inc.

Guilford, United States

Representative

Jonathan Harris

Nutter, McClennen & Fish, LLP

Goods and services

What the mark covers

The products and services INVEA is filed for, grouped by Nice class.

01Class 1 · Chemicals
Biochemical preparations for the treatment of inflammatory diseases and disorders, including the central nervous system, enteric nervous system, immune system, gastrointestinal tract and dermatologic diseases and disorders, including atopic dermatitis, chronic urticaria, and prurigo nodularis; all these goods excluding food supplements, dietetic food preparations and ingredients and other dietetic products
05Class 5 · Pharmaceuticals
Pharmaceutical preparations and substances for the treatment of gastrointestinal and hepatobiliary diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders and diseases relating to the gut-brain axis, involving the central nervous system, enteric nervous system, immune system, gastrointestinal tract, and dermatology; chemical preparations for the treatment of inflammatory diseases and disorders, including the central nervous system, enteric nervous system, immune system, gastrointestinal tract and dermatologic diseases and disorders, including atopic dermatitis, chronic urticaria, and prurigo nodularis ; biological preparations for the treatment of inflammatory diseases and disorders, including the central nervous system, enteric nervous system, immune system, gastrointestinal tract and dermatologic diseases and disorders, including atopic dermatitis, chronic urticaria, and prurigo nodularis; Pharmaceutical preparations for the treatment of gastrointestinal and hepatobiliary diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and immune system-related disorders; Pharmaceutical preparations in the field of gastrointestinal and hepatobiliary diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and immune system-related disorders; all these goods/services excluding food supplements, dietetic food preparations and ingredients and other dietetic products; the mark is used as a house mark for the goods identified in the instant application

History

What has happened so far

Steps recorded by the USPTO, newest first.

October 13, 2026Notice of approval of extension request e-mailed
October 12, 2026Sou extension 2 granted
October 12, 2026Sou extension 2 filed
October 12, 2026Sou teas extension received
April 14, 2026Notice of approval of extension request e-mailed
April 13, 2026Sou extension 1 granted
April 13, 2026Sou extension 1 filed
April 13, 2026Sou teas extension received
October 28, 2025Corrected noa e-mailed
October 28, 2025Post publication amendment - entered

10 earlier steps on the official record.

FAQ

About INVEA

Who owns the trademark "INVEA"?

The USPTO trademark "INVEA" (application 97869600) is owned by Invea Therapeutics, Inc.

What is the status of "INVEA"?

Its status at the USPTO is: allowed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull INVEA and marks like it into your own product with one request.

GET/v1/trademarks/{id}
The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/events
Every step in the office history
GET/v1/proceedings?trademark_id={id}
Oppositions and cancellations against the mark

Get API key View docs

GET /v1/trademarks/{id}

ID=tm_019d2b8c-8a61-7529-acd3-568128cf54f1
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"

Response

{
  "id": "tm_019d2b8c-8a61-7529-acd3-568128cf54f1",
  "object": "trademark",
  "mark_text": "INVEA",
  "status": {
    "primary": "pending",
    "stage": "allowed"
  },
  "office_code": "US",
  "application_number": "97869600",
  "filing_date": "2023-04-03",
  "nice_classes": [
    1,
    5
  ],
  "owners": [
    {
      "name": "Invea Therapeutics, Inc.",
      "entity_id": null
    }
  ]
}